So you have sex. Maybe the condom breaks. Maybe you don’t use one. Or maybe you just forgot to take your contraceptive pill that morning.
At some point in their lives, most women will be in need of the morning-after pill.
And if and when that time comes, it would be nice to know that the pill you take will do that job it’s intended to. Right?
Well, news from Europe today kind of puts that theory into doubt.
The manufacturers of a morning-after pill have revealed that the drug might not work as effectively as it should for women with a high BMI.
Apparently HRA Pharma, the company who make the European drug, Norlevo, are going to update the pill’s packaging to indicate that it is less effective for women who weigh over 165 pounds (which is around 75 kilograms) and that it loses its efficiency altogether when taken by women over 176 pounds (which is approximately 80 kilograms).
Cue panic around the world.
Jezebel reported this morning:
As first reported by Mother Jones, HRA Pharma was originally prompted to look into the effectiveness of their emergency contraception by a 2011 study out of the University of Edinburgh, Scotland that found that “the risk of pregnancy was more than threefold greater for obese women compared with women with normal body mass index, whichever EC [Emergency Contraception] was taken.” They also found that the risk of pregnancy was particularly high if that emergency contraception was made of levonorgestrel, the hormone found in many of the major over-the-counter morning after pills sold in the United States, like Plan B One-Step. The study recommended that overweight women use IUDs.
When Mamamia read the story earlier today, the first thing we wanted to know was how this affects us in Australia.
Because morning-after pills containing levonorgestrel are sold here. And 75 kilograms? That kind of sounds like an average woman.